← Back to Search

Other

Small Phlebotomy Tubes for Anemia in ICU Patients

N/A

Recruiting

Led By Javier Barreda Garcia, MD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up completion of study (up to 90 days from enrollment)

Awards & highlights

Study Summary

This trial evaluates the effectiveness of smaller tubes to reduce RBC transfusions in ICU/IMU patients with low hemoglobin & assess their acceptability.

Who is the study for?

This trial is for adults in the ICU or IMU with anemia, specifically those with hemoglobin levels below 9 g/dL. It's not suitable for patients with active bleeding, blood or bone marrow disorders, Jehovah's Witnesses, those on comfort care only, refractory shock patients, severe acidosis cases without diabetic ketoacidosis, surgical admission diagnoses, pregnant women or prisoners.Check my eligibility

What is being tested?

The study compares small phlebotomy tubes against standard ones to see if they reduce the need for red blood cell transfusions in anemic ICU/IMU patients. It also looks at how these groups differ in terms of ICU/hospital stay length and mortality rates while assessing the acceptability of using small tubes.See study design

What are the potential side effects?

Since this trial involves different sizes of phlebotomy tubes rather than medications or invasive procedures, side effects are minimal and primarily related to discomfort from blood draws.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ completion of study (up to 90 days from enrollment)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~completion of study (up to 90 days from enrollment)

This trial's timeline: 3 weeks for screening, Varies for treatment, and completion of study (up to 90 days from enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants that receive a red blood cell (RBC) transfusion during hospitalization

Secondary outcome measures

Acceptability of small tubes as assessed by determining the number of patients that switch from small tubes to standard tubes

Length of stay in ICU

Length of stay in hospital

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Small Tube GroupExperimental Treatment1 Intervention

Group II: Standard Tube GroupActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

904 Previous Clinical Trials

320,272 Total Patients Enrolled

3 Trials studying Anemia

1,718 Patients Enrolled for Anemia

Javier Barreda Garcia, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

1 Previous Clinical Trials

200 Total Patients Enrolled

1 Trials studying Anemia

200 Patients Enrolled for Anemia

Media Library

Small Phlebotomy Tube Group (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05750654 — N/A

Anemia Research Study Groups: Small Tube Group, Standard Tube Group

Anemia Clinical Trial 2023: Small Phlebotomy Tube Group Highlights & Side Effects. Trial Name: NCT05750654 — N/A

Small Phlebotomy Tube Group (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05750654 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being accepted into this trial?

"According to clinicaltrials.gov, this trial is not currently recruiting patients at the present time; it was initially posted on April 1st 2023 and recently revised on February 25th 2023. Despite that, there are still 224 different medical studies looking for volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia

Javier Barreda Garcia 2023. "Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05750654.

All > Anemia